Showing results (11-20 of 224) with videos related to

Sort By:
Pageof 23
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 26, 2011
Comparative cost-efficiency across the European G5 countries of various regimens of filgrastim, biosimilar filgrastim, and pegfilgrastim to reduce the incidence of chemotherapy-induced febrile neutropeniaMatti Aapro, Paul Cornes, Ivo Abraham
Cancer Treatment and Research Communications|June 12, 2024
On-body injector pegfilgrastim for chemotherapy-induced neutropenia prophylaxis: Current StatusIvo Abraham, Jeffrey Crawford, Lee Schwartzberg
Expert Opinion on Drug Safety|February 20, 2013
Clinical safety of biosimilar recombinant human granulocyte colony-stimulating factorsIvo Abraham, Soba Tharmarajah, Karen MacDonald
Expert Opinion on Drug Safety|October 1, 2022
Changing paradigms in detecting rare adverse drug reactions: from disproportionality analysis, old and new, to machine learningDaniel Arku, Consuela Yousef, Ivo Abraham
Expert Opinion on Biological Therapy|July 26, 2023
The status and preparation for the next decade of biosimilars in the Middle Eastern and North African regionNimer S Alkhatib, Shiraz Halloush, Ivo Abraham
Journal of Medical Economics|February 1, 2024
The economic burden of Ebola virus disease: a review and recommendations for analysisMavis Obeng-Kusi, Jennifer Martin, Ivo Abraham
Pageof 23